Skip to main content

Market Overview

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)

471.23 +9.66 (2.09%)

Analyst Ratings

DateResearch FirmActionCurrentPT
2/23/21Credit SuisseMaintainsOutperform760.0
2/16/21Cantor FitzgeraldMaintainsOverweight656.0
2/08/21Cowen & Co.MaintainsOutperform565.0
2/08/21Credit SuisseMaintainsOutperform753.0
2/08/21Morgan StanleyMaintainsEqual-Weight525.0
2/08/21SVB LeerinkMaintainsOutperform640.0
1/25/21BMO CapitalUpgradesOutperform630.0
1/19/21Morgan StanleyMaintainsEqual-Weight553.0
1/14/21CitigroupMaintainsBuy584.0
1/13/21BenchmarkUpgradesBuy590.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter